/ /

Lisette Hilton
Lisette Hilton is president of Words Come Alive, based in Boca Raton, Florida.
5 tips to enhance the surgical experience
Drs. Charlene Lam and Elizabeth Billingsley offer insights to optimize the surgical experience for dermatologists and their patients.
6 considerations before making that laser purchase
Choosing the right laser devices can add to the bottom line and patient satisfaction; choosing the wrong devices can be a drain on a practice’s viability.
The future of wound healing
The future of wound healing
Researchers have developed a 3D printer that applies skin cells onto burn wounds. Bio-printed cells enhanced wound healing by three to four weeks compared with untreated or matrix-treated wounds. Researchers are compiling animal data to submit an IND application for a clinical trial.
Hologic to Acquire Cynosure
Hologic, a global healthcare and diagnostics company focused on woman’s health, announced Feb. 14, 2017, that it signed a definitive agreement to acquire all outstanding Cynosure shares, an equity value estimated at $1.65 billion.
Allergan to acquire CoolSculpting’s maker Zeltiq
Allergan has announced that it has agreed to acquire ZELTIQ Aesthetics for $2.475 billion, a deal expected to close in the second half of the year.
How to test kids for diabetes
Testing glycated hemoglobin (HbA1c) appears to predict children’s diabetes risk as well as fasting plasma glucose and 2-hour postload plasma glucose, according to a study on more than 2000 American Indian children.
New guidelines for early peanut exposure
New recommendations for infant exposure to peanuts to prevent peanut allergy address something many pediatricians have long suspected: Early exposure to peanuts, even in infants that have eczema, could prevent development of peanut allergy.
Updated guidelines for diagnosis, treatment of rosacea
A revised and updated set of criteria and treatment recommendations establishes a phenotype approach to diagnosing and classifying rosacea. This approach marks a transition from treating rosacea patients according to subtype. Global representation may identify research needed to determine whether rosacea is a global condition.
Guidelines recommend early peanut introduction
Experts weigh in on what to know about the new addendum to the peanut allergy prevention guidelines.
New neurotoxin on the block starts phase 3 trials
The injectable neurotoxin drug candidate daxibotulinumtoxinA for injection (RT002, Revance Therapeutics) started phase 3 SAKURA trials in December 2016

Poll

View Results